General MedicationsORALStandard

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Standard Dose

1.6GM/BOT;3.13GM/BOT;17.5GM/BOT

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE is listed in Drugs@FDA under application 215469 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE Form and strength SOLUTION;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT Sponsor STRIDES PHARMA INTL Submission history Latest submission status date: 2023-11-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE is listed in Drugs@FDA under application 215469 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE Form and strength SOLUTION;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT Sponsor STRIDES PHARMA INTL Submission history Latest submission status date: 2023-11-22 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.